Search results
Results From The WOW.Com Content Network
The pregnancy category of a medication is an assessment of the risk of fetal injury due to the pharmaceutical, if it is used as directed by the mother during pregnancy. It does not include any risks conferred by pharmaceutical agents or their metabolites in breast milk. Every drug has specific information listed in its product literature.
Topical nicotinamide and topical zinc are safe, however, there are no FDA pregnancy category ratings. [27] [28] Topical salicylic acid and topical dapsone are classified as FDA pregnancy category C. [23] [28] Acne medications to avoid during pregnancy include oral isotretinoin and topical tazarotene as there have been reports of birth defects.
The FDA originally labeled rabeprazole as a pregnancy category B drug (meaning that in vivo research failed to demonstrate a fetal hazard, though human studies are lacking), [17] but it was reclassified as a pregnancy category C drug (meaning that in vivo research has shown a fetal hazard, though the benefit of use may outweigh the risk) in 2014.
Serious side effects may include low blood pressure and heart failure. [2] Nifedipine is considered safe in pregnancy and breastfeeding. [5] Nifedipine was patented in 1967, and approved for use in the United States in 1981. [2] [6] [7] It is on the World Health Organization's List of Essential Medicines. [8] It is available as a generic ...
Common side effects include itching, facial swelling, headaches, and feeling tired. [3] Other side effects include vision loss and dizziness. [3] It is a recommended treatment in pregnancy and appears to be safe for the baby. [4] [5] The World Health Organization; however, recommends waiting until after pregnancy for treatment when feasible. [2]
Hydroxyprogesterone caproate is generally well tolerated and produces few side effects. [1] Injection site reactions such as pain and swelling are the most common side effect of hydroxyprogesterone caproate. [1] The medication may increase the risk of gestational diabetes when used in pregnant women.
It is a first-line treatment for amebiasis or giardiasis during pregnancy. [3] Otherwise, it is generally a second line treatment option. [3] It is taken by mouth, applied to the skin, or by injection into a muscle. [3] Common side effects when taken by mouth include loss of appetite, vomiting, abdominal pain, and diarrhea. [3]
Common side effects include abdominal pain, cough, and headache. [6] Severe side effects may include allergic reactions, such as anaphylaxis and eosinophilia. [6] Use in pregnancy appears to be safe. [6] Montelukast is in the leukotriene receptor antagonist family of medications. [6]